COVID-19 | Top 10 Global Developments This Morning

ANI file photo

1. The United States continues to remain the worst affected due to COVID-19 with the death toll in the country surpassing 5,00,000 on Monday (local time).

2. Dr Anthony Fauci, the top US infectious disease expert, said political divisiveness contributed significantly to the “stunning” national Covid-19 death toll.

3. In view of the spread of COVID-19, United Kingdom Prime Minister Boris Johnson on Monday announced a ban on non-essential international travel from and to the country till at least May 17.

4. The World Health Organization has agreed a no-fault compensation plan for claims of serious side effects in people in 92 poorer countries due to get COVID-19 vaccines via the Covax sharing scheme, resolving a big concern among recipient governments, Reuters reports.

ALSO READ: COVID-19 | Top 10 Developments In India This Morning

5. China reported 10 new Covid cases on 22 February, down from 11 cases a day earlier, the national health authority said on Tuesday.

6. Syria has authorised the use of Russia’s Sputnik V coronavirus vaccine, its embassy in Moscow said Monday, AFP reports.

7. France reported a further 333 deaths from Covid-19, as well as 4,646 new infections, an increase from last Monday’s daily case tally of 4,376.

8. In view of the COVID-19 pandemic, Italian Prime Minister Mario Draghi on Monday extended the ban on travel between the country’s 20 regions till March 27.

9. Australia will ramp up its Covid immunisation drive with more shots to be rolled out from next week, federal Health Minister Greg Hunt said on Tuesday, after a second shipment of the vaccine reached the country overnight.

10. Malaysia recorded 2,192 new confirmed cases of COVID-19, bringing its total tally to 285,761, its health ministry said on Monday.

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram


Please enter your comment!
Please enter your name here